Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec 12:6:295-316.
doi: 10.2147/CCID.S50546.

Dermal fillers in aesthetics: an overview of adverse events and treatment approaches

David Funt  1 , Tatjana Pavicic  2
Affiliations
Review

Dermal fillers in aesthetics: an overview of adverse events and treatment approaches

David Funt et al. Clin Cosmet Investig Dermatol. .

Abstract

Background: The ever-expanding range of dermal filler products for aesthetic soft tissue augmentation is of benefit for patients and physicians, but as indications and the number of procedures performed increase, the number of complications will likely also increase.

Objective: To describe potential adverse events associated with dermal fillers and to provide structured and clear guidance on their treatment and avoidance.

Methods: Reports of dermal filler complications in the medical literature were reviewed and, based on the publications retrieved and the authors' extensive experience, recommendations for avoiding and managing complications are provided.

Results: Different dermal fillers have widely varying properties, associated risks, and injection requirements. All dermal fillers have the potential to cause complications. Most are related to volume and technique, though some are associated with the material itself. The majority of adverse reactions are mild and transient, such as bruising and trauma-related edema. Serious adverse events are rare, and most are avoidable with proper planning and technique.

Conclusion: For optimum outcomes, aesthetic physicians should have a detailed understanding of facial anatomy; the individual characteristics of available fillers; their indications, contraindications, benefits, and drawbacks; and ways to prevent and avoid potential complications.

Keywords: aesthetic medicine; complications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bruising may be immediate or worsen over 3 days.
Figure 2
Figure 2
Acute generalized facial edema.
Figure 3
Figure 3
Malar edema.
Figure 4
Figure 4
The anatomic basis of malar edema. Notes: Pessa JE, Garza JR., Aesthet Surg J. 17(1):11–17. Copyright © 1997 by MOSBY, INC. Reprinted by Permission of SAGE Publications.
Figure 5
Figure 5
Erythema at site of injection.
Figure 6
Figure 6
Dyschromia and visible material.
Figure 7
Figure 7
Dermal filler injection leading to herpes virus reactivation.
Figure 8
Figure 8
Noninflammatory nodule.
Figure 9
Figure 9
Inflammatory foreign body granuloma before and after treatment with an antibiotic, 5-FU, triamcinolone, and local anesthetic. Abbreviation: 5-FU, 5-fluorouracil.
Figure 10
Figure 10
Nodularity that proved to be foreign body granuloma on surgical biopsy.
Figure 11
Figure 11
Facial artery anatomy illustrating the most common sites of vascular occlusion. Notes: Reproduced with permission. Copyright © 2009, John Wiley and Sons. Grunebaum LD, Bogdan Allemann I, Dayan S, Mandy S, Baumann L. The risk of alar necrosis associated with dermal filler injection. Dermatol Surg. 2009;35 Suppl 2:1635–1640.
Figure 12
Figure 12
Retinal artery occlusion as a result of calcium hydroxylapatite in the central retinal artery.
Figure 13
Figure 13
Skin necrosis after dermal filler injection.
Figure 14
Figure 14
Examples of tissue necrosis after vascular compromise.
Figure 15
Figure 15
Progression of vascular compromise after an embolic event.
See this image and copyright information in PMC

References

    1. American Society for Aesthetic Plastic Surgery Cosmetic surgery national data bank statistics 2012. [Accessed September 13, 2013]. Available from: http://www.surgery.org/sites/default/fles/ASAPS-2011-Stats.pdf.
    1. Rzany B, Hilton S, Prager W, et al. Expert guideline on the use of porcine collagen in aesthetic medicine. J Dtsch Dermatol Ges. 2010;8(3):210–217. - PubMed
    1. Goldberg DJ. Legal ramifications of off-label filler use. Dermatol Ther. 2006;19(3):189–193. - PubMed
    1. Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg. 2008;34(Suppl 1):S105–S109. - PubMed
    1. Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study) Dermatol Surg. 2008;34(3):326–335. - PubMed